Get started Log in

ARAV — Aravive Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
$2.95m
Enterprise Value
-$5.59m
Revenue
$9.14m

Brief: Aravive To Delist From Nasdaq
17/01/2024 21:10
Brief: Aravive Received Notice Of Delisting From Nasdaq
19/09/2023 22:45
U.S. RESEARCH ROUNDUP-Appfolio, Iron Mountain, Neogenomics
22/08/2023 08:13
Aravive Inc reports results for the quarter ended in June - Earnings Summary
21/08/2023 22:59
Aravive Inc expected to post a loss of 28 cents a share - Earnings Preview
07/08/2023 19:34
U.S. STOCKS ON THE MOVE-Upwork, Sunrun, Regeneron Pharma
03/08/2023 12:54
Aravive falls after cancer treatment fails in late-stage study
02/08/2023 23:37
U.S. RESEARCH ROUNDUP-Cava Group, Citizens Financial, Integral Ad Science Holding
10/07/2023 08:22
Brief: Aravive Files For Mixed Shelf Of Up To $250 Million – SEC Filing
20/06/2023 21:54
Brief: Aravive To Present Promising Updated Data From Phase 2 Trial Of Batiraxcept In Combination With Cabozantinib In Clear Cell Renal Cell Carcinoma At ASCO 2023
25/05/2023 23:08
Brief: Aravive Announces Phase 3 Trial Design For Batiraxcept In Clear Cell Renal Cell Carcinoma
16/05/2023 12:11
Brief: Aravive Reports Q1 Loss Per Share $0.66
10/05/2023 22:11
Aravive Inc reports results for the quarter ended in March - Earnings Summary
10/05/2023 22:04
Aravive Inc expected to post a loss of 32 cents a share - Earnings Preview
08/05/2023 18:59
Brief: Aravive Reports Fourth Quarter Results
15/03/2023 11:52
U.S. STOCKS ON THE MOVE-First Solar, Iveric Bio, Salesforce
01/03/2023 19:25
U.S. STOCKS ON THE MOVE-Wendy's, HP, Sanofi
01/03/2023 14:23
Aravive rises on FDA's 'orphan drug' tag for pancreatic cancer drug
01/03/2023 12:12
Brief: Aravive Announces FDA Orphan Drug Designation Granted To Batiraxcept For The Treatment Of Pancreatic Cancer
28/02/2023 22:21
Brief: Aravive Announces Enrollment In The Global Registrational Phase 3 Axlerate-OC Trial For Platinum-Resistant Ovarian Cancer
04/01/2023 12:12